Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT-Reference-Cited by-同舟云学术

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Published:2023-08-08 Issue:11 Volume:58 Page:1197-1202
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sanz Jaime^ORCID,Labopin Myriam^ORCID,Pabst Thomas^ORCID,Versluis Jurjen^ORCID,Van Gorkom Gwendolyn,Meijer Ellen,Gedde-Dahl Tobias,Montoro Juan^ORCID,Arcese William,Pérez-Simón Jose Antonio^ORCID,Schaap Nicolaas,Maertens Johan,Vrhovac Radovan,Lanza Francesco^ORCID,Gorin Norbert Claude^ORCID,Mohty Mohamad^ORCID,Ciceri Fabio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02075-4.pdf

Reference24 articles.

1. Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.

2. Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217–39.

3. Gorin N-C, Labopin M, Czerw T, Pabst T, Blaise D, Dumas P-Y, et al. Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: a retrospective study from the Acute Leukemia Working Party of the Europe. Cancer. 2017;123:824–31.

4. Gorin NC, Labopin M, Blaise D, Dumas PY, Pabst T, Trisolini SM, et al. Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remiss. Am J Hematol. 2018;93:859–66.

5. Harada M, Akashi K, Hayashi S, Eto T, Takamatsu Y, Teshima T, et al. Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission. Int J Hematol. 1997;66:297–301.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML;Annals of Hematology;2024-01-25